• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 28
  • 13
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 70
  • 9
  • 9
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
31

Desenvolvimento de um complexo biopolímero-íon metálico matricial microparticulado para adsorção de substâncias / Development of a biopolymer-metallic ion microparticulated complex to substance adsorption

Reynaud, Franceline January 2009 (has links)
Micropartícula de quitosana complexada com íons metálicos [Fe(II), Fe(III), Zn(II)] foram preparadas e caracterizadas a fim de se obter sistemas microparticulados para a adsorção de substâncias. A técnica de preparo utilizada foi a secagem por aspersão, através da qual se obteve micropartículas esféricas colapsadas e com superfície rugosa. O tamanho de partícula foi influenciado tanto pela reação de reticulação com glutaraldeído como pela presença e tipo do metal utilizado para a formação do complexo. A adsorção do ciprofloxacino pelas micropartículas desenvolvidas foi estudada em meio aquoso, O estado de equilíbrio foi influenciado pelo tipo de metal presente na micropartícula e pela concentração inicial de ciprofloxacino na solução. Com o intuito de descrever o mecanismo de adsorção, foram utilizados modelos matemáticos de isotermas de Langmuir e Freundlich, sendo que os dados apresentaram um melhor ajuste para a isoterma de Freundlich. Através da análise de modelos de cinética de pesudo-primeira-ordem e pseudo-segunda-ordem, verificou-se que os dados melhor se ajustaram ao modelo de pseudo-segunda-ordem, indicando que o mecanismo de adsorção do ciprofloxacino pelas micropartículas é através de quimissorção. A determinação da capacidade de adsorção do ciprofloxacino, conduzido in vitro, demonstrou que as micropartículas de quitosana-Fe(III) e quitosana-Zn(II) apresentam efetividade de adsorção. Com isso as micropartículas de quitosana-Fe(III) foram encapsuladas por uma matriz de pectina, sendo este utilizado para a adsorção de antimicrobianos residuais presentes no cólon. A estabilidade das esferas foi determinada em meios digestivos simulados, onde se verificou uma estabilidade de 1 h e 5 h nos meios gástricos e intestinal, respectivamente. Quando as esferas foram incubadas no meio colônico, observou-se uma degradação dependente da concentração de pectina. Com o intuito de evitar a adsorção do ciprofloxacino no meio intestinal, as esferas foram revestidas com Eudragit RS. Estudos de adsorção em meio colônico simulado demonstrou que a capacidade de adsorção das micropartículas de quitosana-Fe(III) não é afeta pela encapsulação na matriz de pectina. O sistema desenvolvido demonstra ser promissor para a extração do ciprofloxacino presente no meio colônico simulado. / The aim of this work was to develop, characterize chitosan- metal ion [Fe(II), Fe(III), Zn(II)] microparticle, and evaluate the adsorption capacities of ciprofloxacin by these complexes. The microparticles were prepared by a spray drying method. They showed good sphericity and a roughness surface morphology. The particle size was influenced by crosslinking reaction and by the kind of metal ion onto the microparticle. A batch adsorption system was applied to study the adsorption of ciprofloxacin from aqueous solution by chitosan-metal ion crosslinked microparticle. The adsorption process was fast, and the equilibrium contact times were influenced by the kind of metal ion onto microparticle. The Langmuir and Freundlich adsorption models were used for mathematical description of the adsorption equilibrium, and it was found that experimental data fitted well to Freundlich model. Adsorption models, based on the assumption of the pseudo-first-order and pseudo-second-order mechanism showed that the pseudo-second-order adsorption mechanism is predominant, and the adsorption process appears to be controlled by the chemical reaction. Chitosan-Fe(III) and chitosan-Zn(II) microparticle demonstrated the highest adsorption of ciprofloxacin. Chitosan-Fe(III) microparticle was encapsulated in a pectin matrix. The system was used for the adsorption of colonic residual antibiotics responsible by the emergence of resistance. The stability of the beads was carried out on simulated digestive media. Beads incubated in simulated gastric and intestinal medium were stable for 1 h and 5 h, respectively. When incubated in simulated colonic medium, beads were then degraded by pectinases contained in the medium. Coating with Eudragit RS was needed to prevent the early adsorption of antibiotics in intestinal medium. Adsorption studies in simulated colonic medium show that the adsorption capacity of chitosan-Fe(III) is not modified after encapsulation within pectin beads making the elimination reaching the colon clinically feasible.
32

Revestimento polimerico e farmacocinetica de granulos gastrorresistentes contendo didanosina incorporada em microparticulas de quitosana / Polymeric coating and pharmacokinetic of chitosan granules containing ddI incorporated in microparticles

Severino, Patrícia 12 August 2018 (has links)
Orientadores: Maria Helena Andrade Santana, Teresa Cristina Tavares Dalla Costa / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Engenharia Quimica / Made available in DSpace on 2018-08-12T21:30:18Z (GMT). No. of bitstreams: 1 Severino_Patricia_M.pdf: 4524710 bytes, checksum: fdcb20a724ed2aef9bf5d176f8e8540f (MD5) Previous issue date: 2008 / Resumo: Neste trabalho foram estudados a produção e farmacocinética de uma nova formulação do fármaco didanosina (ddI), composta de grânulos de quitosana contendo a ddI incorporada em micropartículas, para administração por via oral no tratamento da AIDS. As vantagens dessa nova forma farmacêutica são: assegurar a estabilidade da ddI no meio gastrintestinal, produzir adesão à membrana intestinal proporcionando assim melhor absorção através do aumento da permeação e liberação controlada, facilitar o manuseio (fracionamento de comprimidos e ajuste da dose) e deglutição em relação à forma farmacêutica convencional (compridos ou cápsulas revestidas), principalmente para idosos e crianças. O estudo abrangeu os seguintes aspectos: otimização do carregamento da ddI em micropartículas de quitosana previamente desenvolvidas por Silva, 2006; produção dos grânulos em leito fluidizado e por extrusão/esferonização; revestimento polimérico gastrorresistente em leito fluidizado; e obtenção dos perfis farmacocinéticos plasmáticos em cães através da administração oral dos grânulos produzidos. A otimização do carregamento da ddI foi realizada através de modificações nas condições fluidodinâmicas do processo de produção das micropartículas. A produção e o revestimento dos grânulos foram realizados em leito fluidizado, avaliando as variáveis do processo e utilizando a suspensão polimérica Kollicoat® MAE 100 P para o revestimento gastroressistente, já que a ddI sofre desacetilação e torna-se ineficaz farmacologicamente quando exposta ao pH gástrico. Os perfis farmacocinéticos plasmáticos em cães foram analisados por modelo não-compartimental. Os resultados experimentais mostraram que através das modificações das condições fluidodinâmicas conseguimos aumentar a encapsulação da ddI em micropartículas em 13,3%, em relação a formulação inicialmente desenvolvida por SILVA, 2006. O revestimento entérico dos grânulos mostrou-se adequado em estudos in vitro, como preconizado pela farmacopéia. A metodologia analítica por CLAE acoplada a extração em fase sólida desenvolvida mostrou-se adequada para a quantificação do ddI e foi validada para determinação simultânea de ddI e ACL (padrão interno), em amostras de plasma de cão. Os perfis cinéticos mostraram que a nova formulação apresenta-se estatisticamente diferente das distribuídas no SUS, devido a sua liberação modificada de 36 horas. Estes resultados contribuem para o desenvolvimento de novas formas farmacêuticas de administração oral, liberação modificado, requerendo menor frequência de administração, proporcionando maior adesão ao tratamento em várias patologias / Abstract: This work studied the production and pharmacokinetic of a new pharmaceutical formulation of the didanosine (ddI) drug ,composed by chitosan granules containing ddI incorporated in microparticles, for oral administration in the AIDS therapy. The advantages of this new pharmaceutical formulation compared to the conventional one are: to assure ddI stability in gastrointestinal medium, to produce adhesion to intestinal membrane, enhancing absorption through the increasing of permeation and controlled release and to facilitate the handling and deglutition especially to elderly and children. The approach included the following aspects: optimization of the ddI amount in the chitosan microparticles previously developed by Silva, 2006; production of granules in fluidized bed and by extrusion/spheronization; polymeric gastroresistent coating in fluidized bed and acquiring of the plasmatic pharmacokinetic profiles in dogs through oral administration of the produced granules. The optimization of ddI amount in granules was carried out through modifications on the fluid-dynamic conditions of the process for production of the microparticles. The production and coating were carried out in fluidized bed, evaluating the variables of the process. A polymeric suspension of Kollicoat® MAE 100 P for coated enteric coating was used, because the ddI suffers desacetilation and losses its pharmacological efficacy when exposed to the gastric pH. The plasmatic pharmacokinetic profiles in dogs were analyzed by non-compartimental models. The experimental results shown that the encapsulation of ddI in microparticles was increased 13.3% compared to the previous formulation developed by Silva 2006, when modified fluid-dynamic conditions were introduced in the production process. The enteric coating of the granules was suitable as evaluated in vitro according to pharmacopeia. The analytical CLAE methodology associated to extraction in solid phase was adequated for the quantification of ddI. This methodology was validated to determine simultaneously ddI and ACL (internal standard) in samples of dog's plasma. The kinetic profiles shown that the new formulation is statistically different of the formulations distributed by SUS due to its controlled delivery along 36 hours. These results contribute for development new pharmaceutical form for oral administration. That possibility controlled liberation, requiring lower administration frequency, promoting treatment adhesion in a lot of diseases / Mestrado / Desenvolvimento de Processos Biotecnologicos / Mestre em Engenharia Química
33

Short-range cytokine gradients to mimic paracrine cell interactions in vitro

Ansorge, Michael, Rastig, Nadine, Steinborn, Ralph, König, Tina, Baumann, Lars, Möller, Stephanie, Schnabelrauch, Matthias, Cross, Michael, Werner, Carsten, Beck-Sickinger, Annette, Pompe, Tilo 07 February 2019 (has links)
Cell fate decisions in many physiological processes, including embryogenesis, stem cell niche homeostasis and wound healing, are regulated by secretion of small signaling proteins, called cytokines, from source cells to their neighbors or into the environment. Concentration level and steepness of the resulting paracrine gradients elicit different cell responses, including proliferation, differentiation or chemotaxis. For an in-depth analysis of underlying mechanisms, in vitro models are required to mimic in vivo cytokine gradients. We set up a microparticle-based system to establish short-range cytokine gradients in a threedimensional extracellular matrix context. To provide native binding sites for cytokines, agarose microparticles were functionalized with different glycosaminoglycans (GAG). After protein was loaded onto microparticles, its slow release was quantified by confocal microscopy and fluorescence correlation spectroscopy. Besides the model protein lysozyme, SDF-1 was used as a relevant chemokine for hematopoietic stem and progenitor cell (HSPC) chemotaxis. For both proteins we found gradients ranging up to 50 µm from the microparticle surface and concentrations in the order of nM to pM in dependence on loading concentration and affinity modulation by the GAG functionalization. Directed chemotactic migration of cells from a hematopoietic cell line (FDCPmix) and primary murine HSPC (Sca-1+ CD150+ CD48-) toward the SDF-1-laden microparticles proved functional short-range gradients in a twodimensional and three-dimensional setting over time periods of many hours. The approach has the potential to be applied to other cytokines mimicking paracrine cell-cell interactions in vitro
34

Microparticles as a new analytical method to study liquid crystal colloids

ZHANG, KE 20 April 2006 (has links)
No description available.
35

Onset of Arizona Road Dust in High Temperature Environment on a Cooled HASTELLOY X Surface

Nguyen, Vy Thuy 11 June 2018 (has links)
In the past several decades there has been an increased interest in sand, dust, and ash particulates ingestion study for gas turbine engine applications. Recently, there has been an increase in commercial and military fleets operating in medium to highly dusty environments, such as areas in Africa, the Middle East, and Asia. Dusty environments can cause blockage in turbine cooling circuits which can lead to early engine maintenance or removals. Ingested debris can melt, forming glassy or molten deposits on various hot section components in gas turbine engines. This thesis evaluates the onset of deposit formation using an experimental rig to perform testing in high temperature environment. In general, deposits on turbine components can affect the operating capacity and the overall operating efficiency of gas turbine engines. Particulate ingestion events can be catastrophic and cost millions of dollars in maintenance and repairs. The experimental work in this thesis focused only on quantifying the initial deposit formation in high temperature environment to aid in the development of resilient engine design and operational diagnostics. Testing was performed using HASTELLOY® X coupons and Arizona Road Dust with main gas flow temperatures between 1050°C and 1100°C. Arizona Road Dust sample with sizing between 2µm and 40µm were used for experimental testing. The sensitivity of the initial deposit formation on cooled HASTELLOY® X coupon surface was investigated by using an inline air heater. Three cooling test conditions: no cooling, 500°C cooling, and 250°C cooling, were used to alter the surface temperature of the coupon during testing. Results from testing indicated cooling test conditions used have a small impact on deposit formation. / Master of Science / In the past several decades there has been an increased interest in sand, dust, and ash particulates ingestion study for gas turbine engine applications. Recently, there has been an increase in commercial and military fleets operating in medium to highly dusty environments, such as areas in Africa, the Middle East, and Asia. Dusty environments can cause blockage in turbine cooling circuits which can lead to early engine maintenance or removals. Ingested debris can melt, forming glassy or molten deposits on various hot section components in gas turbine engines. This thesis evaluates the onset of deposit formation using an experimental rig to perform testing in high temperature environment. In general, deposits on turbine components can affect the operating capacity and the overall operating efficiency of gas turbine engines. Particulate ingestion events can be catastrophic and cost millions of dollars in maintenance and repairs. The experimental work in this thesis focused only on quantifying the initial deposit formation in high temperature environment to aid in the development of resilient engine design and operational diagnostics. Testing was performed using HASTELLOY® X coupons and Arizona Road Dust with main gas flow temperatures between 1050°C and 1100°C. Arizona Road Dust sample with sizing between 2µm and 40µm were used for experimental testing. The sensitivity of the initial deposit formation on cooled HASTELLOY® X coupon surface was investigated by using an inline air heater. Three cooling test conditions: no cooling, 500°C cooling, and 250°C cooling, were used to alter the surface temperature of the coupon during testing. Results from testing indicated cooling test conditions used have a small impact on deposit formation.
36

Supercritical fluid processing of proteins: lysozyme precipitation from aqueous solution.

Moshashaee, S., Bisrat, M., Forbes, Robert T., Quinn, Ellis A., Nyqvist, H., York, Peter January 2003 (has links)
No / Aqueous solutions of hen egg lysozyme (3% w/v) were dispersed and precipitated by a homogenous mixture of supercritical carbon dioxide-ethanol using the Solution Enhanced Dispersion by Supercritical fluid (SEDS) process. The effects of different working conditions, such as temperature, pressure and the flow rates of the solution and ethanol, on the particle-formation process were studied The morphology, particle size and size distribution and biological activity of the protein were determined The precipitates were examined with high-sensitivity differential scanning calorimetry (HSDSC) and high-performance cation-exchange chromatography Particle size measurements showed the precipitates to be aggregates with primary particles of size 1-5 ¿m. The similarity of HSDSC data for unprocessed and processed samples indicated that the different physical forces that stabilise the native form of lysozyme are unchanged after SEDS processing. From FT-Raman spectroscopic studies secondary structural changes were observed in certain SEDS-produced lysozyme, with most processed samples displaying a slightly more disordered secondary structure than the unprocessed sample However, SEDS samples produced at 200 bar and 40 C exhibited negligible disturbance Thus the SEDS process utilising aqueous solution was able to bring about size reduction of lysozyme with minimal loss of biological activity.
37

Hemolysgränser på Immulite 2000 Xpi vid analys avtillväxthormon (GH) och insulinliknande tillväxtfaktor (IGF-1). / Hemolysis limits on Immulite 2000 Xpi when analyzing growth hormone (GH) and insulin like growth factor(IGF-1).

Matroud, Eslam January 2023 (has links)
Tillväxthormon och insulinliknande tillväxtfaktor-1 är blodprover som tas vid misstanke om akromegali. Immulite 2000 XPi är ett instrument som använder chemiluminescent microparticle immunoassay metodik för att kvantitativt mäta koncentrationen av GH och IGF-1. Analys av biokemiska markörer påverkas av flera olika faktorer. En viktig sådan faktor är hemolys. Hemolys innebär att de röda blodkropparna går sönder, vilket leder till frisättning av dess innehåll såsom hemoglobin i serum/plasma. Syftet med detta projekt var att undersöka hur hemolys påverkar resultatet av GH- och IGF-1-prover på immulite 2000 XPi. Utifrån erhållna resultat kommer klinisk kemi vid Universitetssjukhuset Örebros laboratorie rutiner vid hemolytiska prover på GH eller IGF-1 att uppdateras . Hemolys tillverkades och tillsattes till olika serumprover med låg och hög nivå av GH respektive IGF-1 för att erhålla prover med varierande grad av hemolys. Resultatet visade att ökande hemolysindex korrelerar med GH- respektive IGF-1-koncentrationer, med undantag för den låga GH koncentrationen som inte uppvisade någon korrelation till hemolysindex. En 10%:ig skillnad av GH och IGF-1- koncentrationer uppnåddes vid en ökning av hemolysindex med 555,40 mg/dL för GH respektive 333,3 mg/dL för IGF-1.Utifrån resultaten var hemolysgränsen likvärdig med tillverkarens gränser. Därför kan klinisk kemi på Universitetssjukhuset Örebro fortsätta med nuvarande hemolysgränser. / Growth hormone and insulin-like growth factor-1 are blood samples taken upon suspicion of acromegaly and for follow-up of acromegaly treatment. Immulite 2000 XPi is an instrument that uses chemiluminescent microparticle immunoassay method to quantitatively measure the concentration of GH and IGF-1. Analysis of biochemical markers is affected by several different factors. An important such factor is hemolysis. Hemolysis means that the red blood cells break, whose contents leak into the serum/plasma. The study aimed to investigate how hemolysis affects the results of GH and IGF-1 samples on the Immulite 2000 XPi. The results will determine the routines for hemolytic samples for GH or IGF-1 at Örebro University Hospital. Hemolysis was produced and added to various serum samples with low and high levels of GH and IGF-1 to obtain samples with varying degrees of hemolysis. The results showed that increasing hemolysis index correlates with GH and IGF-1 concentrations, with the exception of low GH concentration, which did not show any correlation to hemolysis index. A 10% difference in GH and IGF-1 concentrations was achieved with an increase in hemolysis index of 555.40 mg/dL for GH and 333.3 mg/dL for IGF-1. Based on the results, the hemolysis limit was equivalent to the manufacturer's limits. Therefore, clinical chemistry at Örebro University Hospital can continue with current hemolysis limits.
38

Síntese e caracterização de derivados de hemoglobina para aplicação terapêutica / Synthesis and characterization of hemoglobin based oxygen carriers for therapeutic application

Knirsch, Marcos Camargo 09 September 2015 (has links)
A transfusão de sangue é uma intervenção terapêutica capaz de salvar muitas vidas. Entretanto, transfusões também apresentam uma alta gama de possíveis eventos adversos, questões logísticas, econômicas e sociais. Dentre as principais preocupações terapêuticas estão a incompatibilidade (principalmente do sistema ABO), a transmissão de microrganismos patogênicos, os distúrbios imunomodulatórios, as reações hemolíticas, o aumento estatístico do risco de morte proporcional ao volume de sangue infundido, dentre outros. Diversas alternativas às transfusões sanguíneas são propostas na literatura científica, dentre elas o desenvolvimento de transportadores de oxigênio que utilizam a hemoglobina, comumente intitulados substitutos sanguíneos. Neste âmbito, o presente estudo teve como objetivo o desenvolvimento de uma rota de síntese e a síntese de partículas de gelatina contendo hemoglobina polimerizada. Para tanto, realizou-se a síntese do polietileno glicol bis-[succinimidil succinato], extraiu-se e polimerizou-se com glutaraldeído ou polietileno glicol bis-[succinimidil succinato] hemoglobina de sangue bovino e, partículas de gelatina coriácea ou óssea contendo hemoglobina polimerizada foram sintetizadas e caracterizadas. A síntese do polietileno glicol bis-[succinimidil succinato] (SSPEG) foi caracterizada por espectroscopia RAMAN, análise diferencial de calorimetria (DSC) e os resultados obtidos indicaram o sucesso das reações. O produto da reação de polimerização da hemoglobina e albumina com o SSPEG foi verificado por SDS-PAGE e os resultados obtidos indicaram a formação com sucesso de polímeros de alta massa molecular. As partículas contendo hemoglobina polimerizada geradas com gelatina coriácea apresentaram diâmetro hidrodinâmico de 1370 nm, dispersividade de 0,029 e potencial zeta de -36,1 mV. As partículas contendo hemoglobina polimerizada geradas com gelatina óssea apresentaram diâmetro hidrodinâmico de 438 nm, dispersividade de 0,563 e potencial zeta de -24,5 mV. Os resultados obtidos sugerem a aplicabilidade da gelatina coriácea para a produção de partículas contendo hemoglobina polimerizada com possível aplicação como transportador de oxigênio. / Blood transfusion is a therapeutic intervention that can save many lives. However, transfusion is also related to several possible adverse therapeutic events and logistic, economic and social concerns. Among the major therapeutic concerns are incompatibility (mainly of the ABO group system), pathogenic microorganisms\' transmission, immunomodulatory disturbances, hemolytic reactions, death risk increase that is proportional to the infused volume, among others. Several alternatives to blood transfusion are proposed in the scientific literature. Among them is the development of hemoglobin based oxygen carriers, commonly entitle blood substitutes. To this extent, the present work aimed to develop a synthetic route and to synthesize gelatin particles containing polymerized hemoglobin. To this purpose PEG bis(succinimidyl succinate) was synthesized, bovine hemoglobin was extracted and polymerized with glutaraldehyde or PEG and polyhemoglobin contained particles of gelatin from leather or bones were synthesized and characterized. PEG bis(succinimidyl succinate) synthesis was characterized by RAMAN spectroscopy and by differential scanning calorimetry (DSC) and the obtained results indicated the successful synthesis. The reaction product of the polymerization of hemoglobin or albumin with PEG was verified by SDS-PAGE and the results indicated the successful formation of high molecular mass polymers. The particles generated with leather gelatin and polyhemoglobin had a hydrodynamic diameter of 1370 nm, dispersity of 0.029 and zeta potential of -36.1 mV. Particles generated with bone gelatin and polyhemoglobin had hydrodynamic diameter of 438 nm, dispersity of 0.563 and zeta potential of -24.5 mV. The obtained results suggest the applicability of leather gelatin for the production of polyhemoglobin containing particles aiming to the development of a hemoglobin based oxygen carrier.
39

Nanopartículas de sílica coloidal como agente da química da parte úmida na fabricação de papel. / Colloidal silica nanoparticles for wet end used for paper machines.

Fernandes, Evanice Torres 01 February 2013 (has links)
No processo de fabricação do papel, a formação é muito importante, pois impacta na qualidade do produto assim como na maquinabilidade e produção. Para uma boa formação, um sistema de retenção e drenagem com aditivos eficientes é muito importante. Desta forma uma sílica nanopartículada, devido a sua área superficial, pode ser a diferença neste sistema e na resistência a úmido na fabricação de papel. Através de testes que simulam a floculação padrão (espalhamento de luz dinâmico) tentou-se identificar qual seriam as variáveis (pH, concentração iônica do meio, tamanho de nanopartícula) que influenciariam no processo de floculação assim como verificar qual o mecanismo e o que ocorre com o floco durante a floculação/defloculação/refloculação. Utilizando como modelo uma máquina de papel offset que usa fibra de celulose branqueada e carga verifica-se a condição de fabricação (receita) e o sistema de retenção e drenagem utilizado atende os parâmetros de resistência e formação da folha de papel. Constatou-se que o pH exerce uma influência no tamanho do floco formado e que o mecanismo de refloculação, para diferentes tipos de cisalhamento, são diferentes. A concentração ideal de sílica e polímero pode ser otimizada a fim de trazer uma redução de custo e melhoria do processo. / In the process of paper manufacturing, formation is important to product quality, runnability and production. To have a good formation, a retention and drainage system with efficient chemicals is important. Thus silica nanoparticles, because their surface area, may be the difference in this systems and wet resistance in the paper manufacture. Using flocculation tests (light dynamic scattering equipment) were identified what conditions (pH, ionic concentration, size particle) had some influence on the flocculation process and verify what is the mechanism and what do happen with the floc during the flocculation/deflocculation/reflocculation. To have an offset paper machine using bleached cellulose and filler, it checked if the mill`s recipe and the retention and drainage system correspond the level of resistance and formation required. I found the pH has had influence in the floc and have had differences in the reflocculation mechanism when submitted to different shears (sonification and stirring). The polymer and silica dosage can be optimized to a saving cost and to improve the process.
40

Parallel manipulation of individual magnetic microbeads for lab-on-a-chip applications

Peng, Zhengchun 19 January 2011 (has links)
Many scientists and engineers are turning to lab-on-a-chip systems for cheaper and high throughput analysis of chemical reactions and biomolecular interactions. In this work, we developed several lab-on-a-chip modules based on novel manipulations of individual microbeads inside microchannels. The first manipulation method employs arrays of soft ferromagnetic patterns fabricated inside a microfluidic channel and subjected to an external rotating magnetic field. We demonstrated that the system can be used to assemble individual beads (1-3µm) from a flow of suspended beads into a regular array on the chip, hence improving the integrated electrochemical detection of biomolecules bound to the bead surface. In addition, the microbeads can follow the external magnet rotating at very high speeds and simultaneously orbit around individual soft magnets on the chip. We employed this manipulation mode for efficient sample mixing in continuous microflow. Furthermore, we discovered a simple but effective way of transporting the microbeads on-chip in the rotating field. Selective transport of microbeads with different size was also realized, providing a platform for effective sample separation on a chip. The second manipulation method integrates magnetic and dielectrophoretic manipulations of the same microbeads. The device combines tapered conducting wires and fingered electrodes to generate desirable magnetic and electric fields, respectively. By externally programming the magnetic attraction and dielectrophoretic repulsion forces, out-of-plane oscillation of the microbeads across the channel height was realized. Furthermore, we demonstrated the tweezing of microbeads in liquid with high spatial resolutions by fine-tuning the net force from magnetic attraction and dielectrophoretic repulsion of the beads. The high-resolution control of the out-of-plane motion of the microbeads has led to the invention of massively parallel biomolecular tweezers.

Page generated in 0.062 seconds